文献速递乳房整形与再造

脱细胞真皮基质与假体乳房再造的成本与结局对照分析

A controlled cost and outcomes analysis of acellular dermal matrix and implant-based reconstruction.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2020-11-08

单中心2010—2016年回顾性研究,将假体乳房再造患者按1:1:1盲法匹配为三组:单期ADM直接假体、两期TE/I无ADM、两期TE/I联合ADM。三组再造成功率无统计学差异(p=0.85),第3组成本显著高于第1、2组,第1、3组外观优于第2组,第1组Breast-Q躯体健康维度评分更高(p=0.01)。

要点

  • 三组再造成功率无显著差异(p=0.85)。
  • 两期TE/I联合ADM组成本显著高于单期ADM组和无ADM两期组。
  • 单期ADM组手术次数和术后随访次数更少(p<0.001)。

核心结论

  • ADM虽增加材料成本,但安全,可省去组织扩张器相关时间与费用,减少术后随访,单期和两期再造均可获得同等功能与美学结局。

研究设计与样本

  • 单中心2010至2016年假体乳房再造回顾性综述,患者按1:1:1盲法匹配为三组:单期ADM直接假体、两期TE/I无ADM、两期TE/I联合ADM。

主要发现

  • 第1组更可能年龄较大并使用术中血管造影,但总手术次数和术后随访次数更少(p<0.001)。
  • 三组再造成功率无统计学显著差异(p=0.85)。
  • 第3组成本显著高于第1组和第2组。
  • 第1组和第3组整体外观评分高于第2组,放疗是唯一独立因素。
  • 第1组Breast-Q躯体健康维度评分更高(p=0.01)。

关键数值与推荐

  • 三组再造成功率比较p=0.85。
  • 第1组手术次数和术后随访次数更少,p<0.001。
  • 第1组Breast-Q躯体健康维度评分更高,p=0.01。

临床怎么用

  • 单期ADM直接假体再造可减少手术和随访次数,但需权衡ADM材料成本。
  • 两期TE/I联合ADM成本更高,选择术式时应结合患者情况和费用考量。
  • 放疗是影响整体外观的独立因素,需在术前评估中纳入。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The use of acellular dermal matrix (ADM) for breast reconstruction continues to change in both single- and two-stage reconstruction. Determining optimal outcomes clinically, aesthetically, financially as well as for the patient's quality of life has become a priority. METHODS: A retrospective review of implant-based reconstructions was performed at a single center from 2010 to 2016, with patients blindly matched 1:1:1 into three cohorts based on reconstruction type: 1) single stage direct to implant with ADM, 2) two-stage tissue expander to implant (TE/I) without ADM, and 3) two-stage TE/I with ADM. Relative cost between groups, esthetic outcomes, and quality of life within each group was analyzed. RESULTS: Group 1 was more likely to be older and use intraoperative angiography, but with fewer overall surgeries and postoperative visits (p<0.001). There was no statistically significant difference in reconstructive success among all three groups (p = 0.85). Cost was significantly higher for group 3 relative to groups 1 and 2. Overall appearance was higher in groups 1 and 3 relative to group 2, with radiation therapy the only independent factor. Group 1 had higher scores using Breast-Q for the physical well-being domain (p = 0.01). CONCLUSION: This is the first study to incorporate clinical outcomes, esthetic visual grading, and patient-reported quality within the same cohort of individuals, considering both use of ADM and staging. Despite the added ADM cost, it is proven safe, eliminates time and cost associated with tissue expanders, decreases post-operative visits and can lead to equally as functional and aesthetically pleasing outcomes in single- and two-stage breast reconstructions.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Aliotta RE, Duraes EFR, Scomacao I, et al. A controlled cost and outcomes analysis of acellular dermal matrix and implant-based reconstruction. J Plast Reconstr Aesthet Surg. 2020. PMID: 33526361. doi:10.1016/j.bjps.2020.10.079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。